2-31583901-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The XM_011533072.3(SRD5A2):c.27-50135A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.685 in 151,688 control chromosomes in the GnomAD database, including 35,813 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.69 ( 35813 hom., cov: 29)
Consequence
SRD5A2
XM_011533072.3 intron
XM_011533072.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.33
Publications
6 publications found
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
SRD5A2 Gene-Disease associations (from GenCC):
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.694 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SRD5A2 | XM_011533072.3 | c.27-50135A>G | intron_variant | Intron 3 of 6 | XP_011531374.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|
Frequencies
GnomAD3 genomes AF: 0.686 AC: 103909AN: 151566Hom.: 35799 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
103909
AN:
151566
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.685 AC: 103967AN: 151688Hom.: 35813 Cov.: 29 AF XY: 0.685 AC XY: 50732AN XY: 74104 show subpopulations
GnomAD4 genome
AF:
AC:
103967
AN:
151688
Hom.:
Cov.:
29
AF XY:
AC XY:
50732
AN XY:
74104
show subpopulations
African (AFR)
AF:
AC:
28556
AN:
41358
American (AMR)
AF:
AC:
10225
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2615
AN:
3466
East Asian (EAS)
AF:
AC:
2510
AN:
5104
South Asian (SAS)
AF:
AC:
2972
AN:
4776
European-Finnish (FIN)
AF:
AC:
7246
AN:
10494
Middle Eastern (MID)
AF:
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47504
AN:
67920
Other (OTH)
AF:
AC:
1464
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1653
3305
4958
6610
8263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1820
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.